Trials / Sponsors / Hangzhou Converd Co., Ltd.
Hangzhou Converd Co., Ltd.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Soli Advanced Solid Tumors | N/A | 2025-06-23 |
| Recruiting | Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 2 | 2025-05-29 |
| Active Not Recruiting | Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors Advanced Solid Tumors | Phase 1 | 2023-07-05 |
| Unknown | Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal C Gastrointestinal Cancer | Phase 1 | 2018-04-01 |
| Unknown | Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors Advanced Solid Tumors | Phase 1 | 2018-04-01 |